A new name for an existing company

Aventus Capital (TSXV:AVTS) is the new name of Westaim Corporation, and the change explains why the TSX Venture Exchange symbol AVTS now appears where WED once did. The company said shares were expected to trade under the new symbol from 17 September 2026, with Share Capital unchanged and existing certificates remaining valid.

The rebrand matters because it signals how management wants the Business understood: as an integrated insurance and alternative asset management platform rather than the Holding Company that investors may have known before.

Business and structure

Aventus is headquartered in Toronto and trades on the TSX Venture Exchange. Its operations sit in two main parts. Ceres Life is described as an artificial-intelligence-native, de novo Annuity insurer. CCaventus, formerly Arena Investors, is an institutional asset manager focused on Credit and asset-oriented investments across corporate, real estate and structured finance.

The release says CC Capital led a 2025 transaction combining Westaim, Arena and Ceres Life, with an Investment of US$250 million. Chinh Chu, founder of CC Capital, is Executive Chair, Cameron MacDonald is chief executive, Erik Askelsen leads Ceres Life and Andrew Rabinowitz leads CCaventus.

Operating markers

As of 31 August 2026, the company said Ceres Life had more than $690 million of premiums issued and pending and $459 million of invested assets. The release does not state the currency, and it gives no assets-under-management figure for CCaventus.

These numbers show a young insurer that is still building its book. Premiums written ahead of invested Assets is typical when annuity business is being bound but cash has yet to be fully deployed, so the gap is not in itself a concern.

Second-quarter results show the cost of growth

A summary of the quarter to 30 June 2026, dated 13 August 2026, reports a net loss of $81.5 million, against a loss of $0.2 million a year earlier, and revenues of $14.0 million, down from $35.1 million. Shareholders' Equity was $540.8 million, and Book Value per fully diluted share was $16.27, compared with $19.60 at the end of 2025. The summary does not state the currency, and it was machine generated, so readers should check the figures against the filed statements.

The same summary says the company cut 31% of headcount, targeting annualised savings of $16.9 million, and completed a $25 million minority investment in Insignia Financial Ltd. It also records a Leadership change at Ceres Life, with Mr Askelsen becoming president and acting chief executive.

Risks to consider

The principal risk is execution. A start-up annuity insurer must grow policies, manage investment returns and control costs at the same time, and early accounting losses can be large before in-force Earnings build. Management has said it expects upfront losses to ease, but that remains an expectation.

Other risks include leadership turnover, dependence on a major shareholder's strategy, credit exposure in the asset manager, and the reduction in equity and book value over the first half of 2026. Thinner trading on a venture exchange can also make prices volatile, and results can swing sharply between quarters while the new businesses mature and costs are reduced.

Milestones to watch

The company held an Investor Day on 17 September 2026 in New York, where it planned to give more detail on assets under management and its financial outlook. The next set of quarterly results should show whether the cost reductions are visible in expenses, whether premium growth continues, and how book value per share moves.

Readers should also watch for further changes to the board and management, additional investments such as the Insignia stake, and regulatory filings from the insurance subsidiary.